AbbVie (ABBV) Interest & Investment Income (2012 - 2026)
AbbVie (ABBV) reported Interest & Investment Income of -$645.0 million for Q1 2026, down 2.87% year-over-year from -$664.1 million in Q1 2025, and up 1.53% on a QoQ basis from -$655.0 million in Q4 2025.
AbbVie (ABBV) has 15 years of Interest & Investment Income data on file, last reported at -$645.0 million in Q1 2026.
- Quarterly Interest & Investment Income fell 2.87% year-over-year to -$645.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 billion (down 13.32% YoY) and the FY2025 annual result came in at -$2.6 billion, down 21.62% from the prior year.
- Interest & Investment Income climbed to -$645.0 million in Q1 2026 per ABBV's latest filing, from -$655.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at -$378.0 million in Q4 2023 and bottomed at -$678.0 million in Q2 2025.
- The 5-year median for Interest & Investment Income is -$532.0 million (2022), against an average of -$538.8 million.
- The widest annual swing landed in 2023, when Interest & Investment Income increased 20.59%; it then plunged 61.38% in 2024.
- Tracing ABBV's Interest & Investment Income over 5 years: stood at -$476.0 million in 2022, then advanced by 20.59% to -$378.0 million in 2023, then sank by 61.38% to -$610.0 million in 2024, then slipped by 7.38% to -$655.0 million in 2025, then grew by 1.53% to -$645.0 million in 2026.
- Per Business Quant, the three latest ABBV Interest & Investment Income figures stand at -$645.0 million (Q1 2026), -$655.0 million (Q4 2025), and -$667.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 229.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -645.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -645.00 Mn |
| Dec 31, 2025 | -655.00 Mn |
| Sep 30, 2025 | -667.00 Mn |
| Jun 30, 2025 | -678.00 Mn |
| Mar 31, 2025 | -627.00 Mn |
| Dec 31, 2024 | -610.00 Mn |
| Sep 30, 2024 | -591.00 Mn |
| Jun 30, 2024 | -506.00 Mn |
| Mar 31, 2024 | -453.00 Mn |
| Dec 31, 2023 | -378.00 Mn |
| Sep 30, 2023 | -398.00 Mn |
| Jun 30, 2023 | -454.00 Mn |
| Mar 31, 2023 | -454.00 Mn |
| Dec 31, 2022 | -476.00 Mn |
| Sep 30, 2022 | -497.00 Mn |
| Jun 30, 2022 | -532.00 Mn |
| Mar 31, 2022 | -539.00 Mn |
| Dec 31, 2021 | -571.00 Mn |
| Sep 30, 2021 | -585.00 Mn |
| Jun 30, 2021 | -606.00 Mn |
| Mar 31, 2021 | -622.00 Mn |
| Dec 31, 2020 | -618.00 Mn |
| Sep 30, 2020 | -620.00 Mn |
| Jun 30, 2020 | -614.00 Mn |
| Mar 31, 2020 | -428.00 Mn |
| Dec 31, 2019 | -455.00 Mn |
| Sep 30, 2019 | -420.00 Mn |
| Jun 30, 2019 | -309.00 Mn |
| Mar 31, 2019 | -325.00 Mn |
| Dec 31, 2018 | -319.00 Mn |
| Sep 30, 2018 | -302.00 Mn |
| Jun 30, 2018 | -272.00 Mn |
| Mar 31, 2018 | -251.00 Mn |
| Dec 31, 2017 | -252.00 Mn |
| Sep 30, 2017 | -252.00 Mn |
| Jun 30, 2017 | -253.00 Mn |
| Mar 31, 2017 | -247.00 Mn |
| Dec 31, 2016 | -290.00 Mn |
| Sep 30, 2016 | -250.00 Mn |
| Jun 30, 2016 | -225.00 Mn |
| Mar 31, 2016 | -200.00 Mn |
| Dec 31, 2015 | -199.00 Mn |
| Sep 30, 2015 | -197.00 Mn |
| Jun 30, 2015 | -164.00 Mn |
| Mar 31, 2015 | -126.00 Mn |
| Dec 31, 2014 | -419.00 Mn |
| Sep 30, 2014 | -128.00 Mn |
| Jun 30, 2014 | -69.00 Mn |
| Mar 31, 2014 | 5.00 Mn |
| Dec 31, 2013 | -68.00 Mn |
| Sep 30, 2013 | -69.00 Mn |
| Jun 30, 2013 | -75.00 Mn |
| Mar 31, 2013 | -66.00 Mn |
| Dec 31, 2012 | 6.00 Mn |
| Sep 30, 2012 | 11.00 Mn |
| Jun 30, 2012 | 2.00 Mn |
| Mar 31, 2012 | 1.00 Mn |